When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CASI - CASI Pharmaceuticals' EVOMELA approved in China
CASI Pharmaceuticals Inc.
CASI Pharmaceuticals (NASDAQ:CASI) has received National Medical Products Administration ("NMPA") approval of Melphalan Hydrochloride For Injection (EVOMELA®), for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma, and
More news on: CASI Pharmaceuticals, Healthcare stocks news, Stocks on the move,